Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
The Pharmacist, a Key Player in the Fight Against the Respiratory Syncytial Virus
2024
This article highlights the important role pharmacists play in fighting respiratory syncytial virus (RSV), especially for infants and people over 60. It describes two main …
Ask aRCie
Effectiveness of Nirsevimab in Infants Against Respiratory Syncytial Virus and Related Events
2024
· Kaiser Permanente
This article discusses a study on nirsevimab, a treatment for infants to prevent respiratory syncytial virus (RSV), which is common in lower respiratory tract diseases. …
Cost-Effectiveness Analysis of Nirsevimab and RSVpreF Vaccine Prevention Strategies for Respiratory Syncytial Virus Disease in Infants: A Canadian Immunisation Research Network (CIRN) Study
2023
· York University,
· Yale University,
· Dalhousie University
This study looks at the cost-effectiveness of two strategies to prevent RSV disease in infants in Canada. It describes using nirsevimab, a long-acting antibody, for …
Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper
2021
· University of Parma,
· University of British Columbia,
· University of Florence,
· Association Française de Pédiatrie Ambulatoire (AFPA),
· Launceston General Hospital,
· University of Tasmania
This article explores the use of anti-viral monoclonal antibodies (mAbs) with routine pediatric vaccines, focusing on nirsevimab for RSV prevention. It describes how mAbs can …
Nirsevimab Reduces Medically Attended RSV-Associated Lower Respiratory Tract Infection and Hospitalisations in Healthy Pre-Term Infants
2022
· University College Cork
This article comments on a study on how nirsevimab helps reduce RSV-related lung infections and hospital visits in healthy pre-term infants. It highlights the benefits …
Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children: A Systematic Review and Network Meta-analysis
2023
· Lanzhou University
This study reviews monoclonal antibodies (mAbs) for preventing respiratory syncytial virus (RSV) in infants and children. It describes how nirsevimab, motavizumab, and palivizumab reduce RSV-related …
Respiratory Syncytial Virus Prevention: A New Era of Vaccines
2023
· Jiangsu University,
· University of Massachusetts,
· Mayo Clinic,
· Johns Hopkins University,
· Rochester Regional Health,
· Mir Neurology
This editorial discusses new vaccines for preventing respiratory syncytial virus (RSV) infections. RSV affects the lungs and can be serious, especially in young children and …
Cost-Effectiveness Analysis of Nirsevimab and Maternal Rsvpref Vaccine Strategies for Prevention of Respiratory Syncytial Virus Disease Among Infants in Canada: A Simulation Study
2023
· Yale University,
· York University,
· Dalhousie University
This study in Canada assessed cost-effectiveness of nirsevimab and RSVpreF for preventing RSV in infants. Modeling different interventions showed immunizing the birth cohort with nirsevimab …
Preventing Respiratory Syncytial Virus in Children in France: A Narrative Review of the Importance of a Reinforced Partnership Between Parents, Healthcare Professionals, and Public Health Authorities
This article describes the importance of preventing respiratory syncytial virus (RSV) in young children in France. It highlights the need for a strong partnership between …
The Efficacy and Safety of Nirsevimab for the Prevention of RSV Infection Among Infants: A Systematic Review and Meta-Analysis
This article describes a study on nirsevimab, a new drug to prevent RSV infections in infants. RSV is a virus that can cause serious lung …